Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$2.45 - $4.1 $1,930 - $3,230
-788 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$3.0 - $4.39 $381 - $557
-127 Reduced 13.88%
788 $3,000
Q4 2020

Feb 10, 2021

BUY
$1.85 - $2.54 $1,692 - $2,324
915 New
915 $2,000
Q2 2020

Aug 12, 2020

SELL
$1.59 - $2.51 $45,171 - $71,309
-28,410 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$1.39 - $3.19 $39,489 - $90,627
28,410 New
28,410 $49,000

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $103M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.